Dr. Ebert leads the only hospital ranked in the top three nationally by U.S. News & World Report for both adult and pediatric cancer care. Since becoming president and CEO, he has guided the institute through a period of accelerating change in cancer medicine, developing a strategic plan that builds on Dana-Farber’s historic strengths while charting bold new directions in areas like education and AI. He is spearheading a clinical collaboration with Boston-based Beth Israel Deaconess Medical Center that will soon break ground on a $1.8 billion 300-bed cancer hospital, making it the only freestanding cancer hospital in New England and expanding access to Dana-Farber’s unique model of care at a time when cancer incidence is on the rise. He leads 500 faculty, 1,000 nurses and 13,000 employees who provide care for 100,000 patients each year. He leads a research enterprise that boasts the highest scientific output per researcher of any institution in the world, according to the National Bureau of Economic Research. Additionally, Dr. Ebert serves as director for the Dana-Farber/Harvard Cancer Center and is the Richard and Susan Smith Professor of Medicine at Harvard Medical School. He is an elected member of National Academy of Medicine, American Academy of Arts and Sciences, and other distinguished societies. In addition, he is the recipient of many of the most prestigious awards in cancer research, including the “William Dameshek Prize,” “Meyenburg Prize,” the “Sjöberg Prize” and the “Korsmeyer Award.”
